 | • レポートコード：QYR9N8081 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、頭頸部治療の扁平上皮がんのグローバル市場について調査・分析したレポートで、種類別（唾液腺、口腔＆中咽頭、鼻腔と副鼻腔、鼻咽頭、喉頭＆下咽頭）、用途別（病院、専門クリニック、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・頭頸部治療の扁平上皮がんの世界市場規模 ・主要企業別市場シェア ・頭頸部治療の扁平上皮がんの世界市場規模：種類別（唾液腺、口腔＆中咽頭、鼻腔と副鼻腔、鼻咽頭、喉頭＆下咽頭） ・頭頸部治療の扁平上皮がんの世界市場規模：用途別（病院、専門クリニック、外来手術センター） ・頭頸部治療の扁平上皮がんのアメリカ市場規模（種類別、用途別） ・頭頸部治療の扁平上皮がんのヨーロッパ市場規模（種類別、用途別） ・頭頸部治療の扁平上皮がんの中国市場規模（種類別、用途別） ・頭頸部治療の扁平上皮がんの日本市場規模（種類別、用途別） ・頭頸部治療の扁平上皮がんの東南アジア市場規模（種類別、用途別） ・頭頸部治療の扁平上皮がんのインド市場規模（種類別、用途別） ・頭頸部治療の扁平上皮がんの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・頭頸部治療の扁平上皮がんの世界市場予測（2019年-2025年） ・頭頸部治療の扁平上皮がんの地域別市場予測（2019年-2025年） ... |
Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Squamous Cell Carcinoma of the Head and Neck Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Squamous Cell Carcinoma of the Head and Neck Treatment development in United States, Europe and China.
The key players covered in this study
Sanofi
Pfizer
Eli Lilly
Bristol-Myers Squibb
Merck
Bayer
Fresenius
Teva Pharmaceutical
AB SCIENCE
AbbVie
Acceleron Pharma
Astellas Pharma
AstraZeneca
Sumitomo Dainippon Pharma
GENERAL ELECTRIC COMPANY
Market segment by Type, the product can be split into
Salivary Gland
Oral & Oropharyngeal
Nasal Cavity & Paranasal Sinus
Nasopharyngeal
Laryngeal & Hypo pharyngeal
Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Squamous Cell Carcinoma of the Head and Neck Treatment status, future forecast, growth opportunity, key market and key players.
To present the Squamous Cell Carcinoma of the Head and Neck Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Squamous Cell Carcinoma of the Head and Neck Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Salivary Gland
1.4.3 Oral & Oropharyngeal
1.4.4 Nasal Cavity & Paranasal Sinus
1.4.5 Nasopharyngeal
1.4.6 Laryngeal & Hypo pharyngeal
1.5 Market by Application
1.5.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Size
2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Growth Trends by Regions
2.2.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions (2014-2025)
2.2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Manufacturers
3.1.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players Head office and Area Served
3.3 Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product/Solution/Service
3.4 Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019)
4.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
5.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in United States
5.3 United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
5.4 United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
6 Europe
6.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
6.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Europe
6.3 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
6.4 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
7 China
7.1 China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
7.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in China
7.3 China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
7.4 China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
8 Japan
8.1 Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
8.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Japan
8.3 Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
8.4 Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
9.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Southeast Asia
9.3 Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
9.4 Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
10 India
10.1 India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
10.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in India
10.3 India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
10.4 India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2014-2019)
11.2 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players in Central & South America
11.3 Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
11.4 Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.1.4 Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.2.4 Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.3.4 Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.4.4 Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.5.4 Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.6.4 Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Fresenius
12.7.1 Fresenius Company Details
12.7.2 Company Description and Business Overview
12.7.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.7.4 Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.7.5 Fresenius Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.8.4 Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.8.5 Teva Pharmaceutical Recent Development
12.9 AB SCIENCE
12.9.1 AB SCIENCE Company Details
12.9.2 Company Description and Business Overview
12.9.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.9.4 AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.9.5 AB SCIENCE Recent Development
12.10 AbbVie
12.10.1 AbbVie Company Details
12.10.2 Company Description and Business Overview
12.10.3 Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
12.10.4 AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
12.10.5 AbbVie Recent Development
12.11 Acceleron Pharma
12.12 Astellas Pharma
12.13 AstraZeneca
12.14 Sumitomo Dainippon Pharma
12.15 GENERAL ELECTRIC COMPANY
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Squamous Cell Carcinoma of the Head and Neck Treatment Key Market Segments
Table Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Covered
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Market Share by Type 2014-2025
Figure Salivary Gland Figures
Table Key Players of Salivary Gland
Figure Oral & Oropharyngeal Figures
Table Key Players of Oral & Oropharyngeal
Figure Nasal Cavity & Paranasal Sinus Figures
Table Key Players of Nasal Cavity & Paranasal Sinus
Figure Nasopharyngeal Figures
Table Key Players of Nasopharyngeal
Figure Laryngeal & Hypo pharyngeal Figures
Table Key Players of Laryngeal & Hypo pharyngeal
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Specialty Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Squamous Cell Carcinoma of the Head and Neck Treatment Report Years Considered
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2025 (Million US$)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions 2014-2019
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions 2014-2019
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Manufacturers (2014-2019)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Manufacturers in 2018
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product/Solution/Service
Table Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Type (2014-2019)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Market Share by Type (2014-2019)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Application (2014-2019)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Market Share by Application (2014-2019)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Application in 2018
Figure United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Figure Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Figure China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-20189) (Million US$)
Table China Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table China Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Figure Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Figure India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table India Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table India Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Figure Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Market Share (2018-2019)
Table Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2014-2019)
Table Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2014-2019)
Table Sanofi Company Details
Table Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019) (Million US$)
Figure Sanofi Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Merck Recent Development
Table Bayer Company Details
Table Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Bayer Recent Development
Table Fresenius Company Details
Table Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Fresenius Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Fresenius Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table AB SCIENCE Company Details
Table AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure AB SCIENCE Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table AB SCIENCE Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Acceleron Pharma Company Details
Table Astellas Pharma Company Details
Table AstraZeneca Company Details
Table Sumitomo Dainippon Pharma Company Details
Table GENERAL ELECTRIC COMPANY Company Details
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Regions (2019-2025)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Regions in 2025
Figure United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Product (2019-2025)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Product in 2025
Table Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2019-2025)
Figure Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の口腔がんの治療市場：市場規模・現状・予測 Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…- 世界の副鼻腔がんの治療市場：市場規模・現状・予測 If cancer is in the ethmoid sinus, treatment may include the following: Surgery followed by radiation therapy. A clinical trial of combination chemotherapy before surgery or radiation therapy. A clinical trial of combination chemotherapy after surgery or other cancer treatment.In 2018, the global Pa…
- 世界の尿路上皮がんの治療市場：市場規模・現状・予測 Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 世界の胸腺がんの治療市場2019 The global Thymic Carcinoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Thymic Carcinoma Treatment market status and forecast, categorizes the global Thymic Carcinoma Treatment…
- 世界の唾液腺感染市場：市場規模・現状・予測 Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.Considering the global scenario of the market, Americas holds the largest market share due to …